Seeking Alpha
 

Arrowhead Research Corporation (ARWR)

- NASDAQ
We currently have no Breaking News on this stock.
Visit Seeking Alpha's
ARWR vs. ETF Alternatives
Company Description
Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
Sector: Healthcare
Industry: Biotechnology
Country: United States